ebe-biopharma.eu
What pricing and reimbursement policies to use for off-patent biologicals? – Results from the second EBE biological medicines policy survey
Methods: The EBE survey was conducted among national pharmaceutical trade associations in 32 countries, the 28 EU Member States plus Norway, Serbia, Switzerland and Turkey. The questionnaire was a revised version of the previous survey of 2014 and was developed by the EBE Biosimilars Working Group. It contained 44 questions about eight policy areas: Availability of